Risk factors for combined hepatocellular-cholangiocarcinoma: A hospital-based case-control study

World Journal of Gastroenterology

Volumn 20, Issue 35, 2014, Pages 12615-12620

  Zhou, Yan Ming ^a   Zhang, Xiao Feng ^b   Wu, Lu Peng ^a   Sui, Cheng Jun ^b   Yang, Jia Mei ^b  

^a XIAMEN UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Alcohol consumption; Combined hepatocellular cholangiocarcinoma; Epidemiology; Hepatitis B virus; Risk factors

Indexed keywords

ALCOHOL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT STONE; BLOOD SAMPLING; CANCER RISK; DIABETES MELLITUS; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; HEPATITIS B; HEPATITIS C; HEPATOCELLULAR CHOLANGIOCARCINOMA; HOSPITAL ADMISSION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; INFLAMMATORY BOWEL DISEASE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL ETHICS; NEEDLE BIOPSY; PRIMARY SCLEROSING CHOLANGITIS; RISK FACTOR; SMOKING; ADVERSE EFFECTS; BILE DUCT NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CHOLANGIOCARCINOMA; COMPLICATION; DIABETES COMPLICATIONS; DRINKING BEHAVIOR; GENETIC PREDISPOSITION; GENETICS; HEREDITY; INTRAHEPATIC BILE DUCT; LIVER NEOPLASMS; MULTIVARIATE ANALYSIS; NEOPLASMS, COMPLEX AND MIXED; PEDIGREE; RISK; STATISTICAL MODEL; UNIVERSITY HOSPITAL;

ALCOHOL DRINKING; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHOLANGIOCARCINOMA; DIABETES COMPLICATIONS; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B; HEREDITY; HOSPITALS, UNIVERSITY; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; NEOPLASMS, COMPLEX AND MIXED; ODDS RATIO; PEDIGREE; RISK FACTORS;

EID: 84909643580     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i35.12615     Document Type: Article

References (48)

1. Yeh MM. Pathology of combined hepatocellular-cholangiocarcinoma. J Gastroenterol Hepatol 2010; 25: 1485-1492 [PMID: 20796144 DOI: 10.1111/j.1440-1746.2010.06430.x]
2. Lee TY, Lee SS, Jung SW, Jeon SH, Yun SC, Oh HC, Kwon S, Lee SK, Seo DW, Kim MH, Suh DJ. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a casecontrol study. Am J Gastroenterol 2008; 103: 1716-1720 [PMID: 18557716 DOI: 10.1111/j.1572-0241.2008.01796.x]
3. Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, Pisters PW, Evans DB, Khan R, Chou TH, Lenzi R, Jiao L, Li D. Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol 2007; 102: 2696-2707 [PMID: 17764494 DOI: 10.1111/j.1572-0241.2007.01510.x]
4. Aoki K, Takayasu K, Kawano T, Muramatsu Y, Moriyama N, Wakao F, Yamamoto J, Shimada K, Takayama T, Kosuge T. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings. Hepatology 1993; 18: 1090-1095 [PMID: 7693572]
5. Haratake J, Hashimoto H. An immunohistochemical analysis of 13 cases with combined hepatocellular and cholangiocellular carcinoma. Liver 1995; 15: 9-15 [PMID: 7539881]
6. Maeda T, Adachi E, Kajiyama K, Sugimachi K, Tsuneyoshi M. Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features. Hum Pathol 1995; 26: 956-964 [PMID: 7545644]
7. Taguchi J, Nakashima O, Tanaka M, Hisaka T, Takazawa T, Kojiro M. A clinicopathological study on combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol 1996; 11: 758-764 [PMID: 8872774]
8. Sasaki M, Yamato T, Nakanuma Y. Expression of sialyl-Tn, Tn and T antigens in primary liver cancer. Pathol Int 1999; 49: 325-331 [PMID: 10365852]
9. Yano Y, Yamamoto J, Kosuge T, Sakamoto Y, Yamasaki S, Shimada K, Ojima H, Sakamoto M, Takayama T, Makuuchi M. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol 2003; 33: 283-287 [PMID: 12913082 DOI: 10.1093/jjco/hyg056]
10. Sanada Y, Shiozaki S, Aoki H, Takakura N, Yoshida K, Yamaguchi Y. A clinical study of 11 cases of combined hepatocellular-cholangiocarcinoma Assessment of enhancement patterns on dynamics computed tomography before resection. Hepatol Res 2005; 32: 185-195 [PMID: 15978872]
11. Aishima S, Kuroda Y, Asayama Y, Taguchi K, Nishihara Y, Taketomi A, Tsuneyoshi M. Prognostic impact of cholangiocellular and sarcomatous components in combined hepatocellular and cholangiocarcinoma. Hum Pathol 2006; 37: 283-291 [PMID: 16613323 DOI: 10.1016/j.humpath.2005.08.019]
12. Wakasa T, Wakasa K, Shutou T, Hai S, Kubo S, Hirohashi K, Umeshita K, Monden M. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma. Hepatogastroenterology 2007; 54: 508-513 [PMID: 17523309]
13. Ariizumi S, Kotera Y, Katagiri S, Nakano M, Yamamoto M. Combined hepatocellular-cholangiocarcinoma had poor outcomes after hepatectomy regardless of Allen and Lisa class or the predominance of intrahepatic cholangiocarcinoma cells within the tumor. Ann Surg Oncol 2012; 19: 1628-1636 [PMID: 22113592 DOI: 10.1245/s10434-011-2150-0]
14. Akiba J, Nakashima O, Hattori S, Tanikawa K, Takenaka M, Nakayama M, Kondo R, Nomura Y, Koura K, Ueda K, Sanada S, Naito Y, Yamaguchi R, Yano H. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification. Am J Surg Pathol 2013; 37: 496-505 [PMID: 23388123 DOI: 10.1097/PAS.0b013e31827332b0]
15. Lee CH, Chang CJ, Lin YJ, Yeh CN, Chen MF, Hsieh SY. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. Br J Cancer 2009; 100: 1765-1770 [PMID: 19436294 DOI: 10.1038/sj.bjc.6605063]
16. Koh KC, Lee H, Choi MS, Lee JH, Paik SW, Yoo BC, Rhee JC, Cho JW, Park CK, Kim HJ. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg 2005; 189: 120-125 [PMID: 15701504 DOI: 10.1016/j.amjsurg.2004.03.018]
17. Lee WS, Lee KW, Heo JS, Kim SJ, Choi SH, Kim YI, Joh JW. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Surg Today 2006; 36: 892-897 [PMID: 16998683 DOI: 10.1007/s00595-006-3276-8]
18. Shin CI, Lee JM, Kim SH, Choi JY, Lee JY, Han JK, Jo SY, Choi BI. Recurrence patterns of combined hepatocellular-cholangiocarcinoma on enhanced computed tomography. J Comput Assist Tomogr 2007; 31: 109-115 [PMID: 17259842 DOI: 10.1097/01.rct.0000235072.34808.9b]
19. Kim KH, Lee SG, Park EH, Hwang S, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma. Ann Surg Oncol 2009; 16: 623-629 [PMID: 19130133 DOI: 10.1245/s10434-008-0278-3]
20. Kim JH, Yoon HK, Ko GY, Gwon DI, Jang CS, Song HY, Shin JH, Sung KB. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization. Radiology 2010; 255: 270-277 [PMID: 20308463 DOI: 10.1148/radiol.09091076]
21. Lee JH, Chung GE, Yu SJ, Hwang SY, Kim JS, Kim HY, Yoon JH, Lee HS, Yi NJ, Suh KS, Lee KU, Jang JJ, Kim YJ. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma. J Clin Gastroenterol 2011; 45: 69-75 [PMID: 20142755 DOI: 10.1097/MCG.0b013e3181ce5dfa]
22. Park H, Choi KH, Choi SB, Choi JW, Kim do Y, Ahn SH, Kim KS, Choi JS, Han KH, Chon CY, Park JY. Clinicopathological characteristics in combined hepatocellular-cholangiocarcinoma: a single center study in Korea. Yonsei Med J 2011; 52: 753-760 [PMID: 21786439 DOI: 10.3349/ymj.2011.52.5.753]
23. Zuo HQ, Yan LN, Zeng Y, Yang JY, Luo HZ, Liu JW, Zhou LX. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2007; 6: 161-165 [PMID: 17374575]
24. Zhang F, Chen XP, Zhang W, Dong HH, Xiang S, Zhang WG, Zhang BX. Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence. Histopathology 2008; 52: 224-232 [PMID: 18184271 DOI: 10.1111/j.1365-2559.2007.02929.x]
25. Yu XH, Xu LB, Zeng H, Zhang R, Wang J, Liu C. Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2011; 10: 620-625 [PMID: 22146626]
26. Yin X, Zhang BH, Qiu SJ, Ren ZG, Zhou J, Chen XH, Zhou Y, Fan J. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis. Ann Surg Oncol 2012; 19: 2869-2876 [PMID: 22451237 DOI: 10.1245/s10434-012-2328-0]
27. Zhan Q, Shen BY, Deng XX, Zhu ZC, Chen H, Peng CH, Li HW. Clinical and pathological analysis of 27 patients with combined hepatocellular-cholangiocarcinoma in an Asian center. J Hepatobiliary Pancreat Sci 2012; 19: 361-369 [PMID: 21744084 DOI: 10.1007/s00534-011-0417-2]
28. Yap AQ, Chen CL, Yong CC, Kuo FY, Wang SH, Lin CC, Liu YW, Lin TL, Li WF, Millan CA, Wang CC. Clinicopathological factors impact the survival outcome following the resection of combined hepatocellular carcinoma and cholangiocarcinoma. Surg Oncol 2013; 22: 55-60 [PMID: 23102615 DOI: 10.1016/j.suronc.2012.09.003]
29. Lee CH, Hsieh SY, Chang CJ, Lin YJ. Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers. J Gastroenterol Hepatol 2013; 28: 122-127 [PMID: 23034166 DOI: 10.1111/j.1440-1746.2012.07289.x]
30. Ng IO, Shek TW, Nicholls J, Ma LT. Combined hepatocellular-cholangiocarcinoma: a clinicopathological study. J Gastroenterol Hepatol 1998; 13: 34-40 [PMID: 9737569]
31. Chantajitr S, Wilasrusmee C, Lertsitichai P, Phromsopha N. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population. J Hepatobiliary Pancreat Surg 2006; 13: 537-542 [PMID: 17139428 DOI: 10.1007/s00534-006-1117-1]
32. Phongkitkarun S, Srisuwan T, Sornmayura P, Jatchavala J. Combined hepatocellular and cholangiocarcinoma: CT findings with emphasis on multiphasic helical CT. J Med Assoc Thai 2007; 90: 113-120 [PMID: 17621741]
33. Jarnagin WR, Weber S, Tickoo SK, Koea JB, Obiekwe S, Fong Y, DeMatteo RP, Blumgart LH, Klimstra D. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 2002; 94: 2040-2046 [PMID: 11932907 DOI: 10.1002/cncr.10392]
34. Panjala C, Senecal DL, Bridges MD, Kim GP, Nakhleh RE, Nguyen JH, Harnois DM. The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma. Am J Transplant 2010; 10: 1263-1267 [PMID: 20420633 DOI: 10.1111/j.1600-6143.2010.03062.x]
35. Cazals-Hatem D, Rebouissou S, Bioulac-Sage P, Bluteau O, Blanché H, Franco D, Monges G, Belghiti J, Sa Cunha A, Laurent-Puig P, Degott C, Zucman-Rossi J. Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas. J Hepatol 2004; 41: 292-298 [PMID: 15288479 DOI: 10.1016/j.jhep.2004.04.030]
36. Portolani N, Baiocchi GL, Coniglio A, Piardi T, Grazioli L, Benetti A, Ferrari Bravo A, Giulini SM. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience. Ann Surg Oncol 2008; 15: 1880-1890 [PMID: 18443881 DOI: 10.1245/s10434-008-9933-y]
37. Theise ND, Yao JL, Harada K, Hytiroglou P, Portmann B, Thung SN, Tsui W, Ohta H, Nakanuma Y. Hepatic 'stem cell' malignancies in adults: four cases. Histopathology 2003; 43: 263-271 [PMID: 12940779 DOI: 10.1046/j.1365-2559.2003.01707.x]
38. Suzuki A, Sekiya S, Onishi M, Oshima N, Kiyonari H, Nakauchi H, Taniguchi H. Flow cytometric isolation and clonal identification of self-renewing bipotent hepatic progenitor cells in adult mouse liver. Hepatology 2008; 48: 1964-1978 [PMID: 18837044 DOI: 10.1002/hep.22558]
39. Huang J, Shen L, Lu Y, Li H, Zhang X, Hu D, Feng T, Song F. Parallel induction of cell proliferation and inhibition of cell differentiation in hepatic progenitor cells by hepatitis B virus X gene. Int J Mol Med 2012; 30: 842-848 [PMID: 22797416 DOI: 10.3892/ijmm.2012.1060]
40. Gao C, Yao SK. Diabetes mellitus: a "true" independent risk factor for hepatocellular carcinoma? Hepatobiliary Pancreat Dis Int 2009; 8: 465-473 [PMID: 19822488]
41. Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol 2012; 57: 69-76 [PMID: 22420979 DOI: 10.1016/j.jhep.2012.02.022]
42. Arao M, Murase K, Kusakabe A, Yoshioka K, Fukuzawa Y, Ishikawa T, Tagaya T, Yamanouchi K, Ichimiya H, Sameshima Y, Kakumu S. Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus. J Gastroenterol 2003; 38: 355-360 [PMID: 12743775]
43. El-Serag HB, Richardson PA, Everhart JE. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans. Am J Gastroenterol 2001; 96: 2462-2467 [PMID: 11513191 DOI: 10.1111/j.1572-0241.2001.04054.x]
44. Shaib YH, El-Serag HB, Nooka AK, Thomas M, Brown TD, Patt YZ, Hassan MM. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol 2007; 102: 1016-1021 [PMID: 17324130 DOI: 10.1111/j.1572-0241.2007.01104.x]
45. Hong CK, Yang JM, Kang BK, Kim JD, Kim YC, Chang UI, Yoo JY. A case of combined hepatocellular-cholangiocarcinoma with underlying schistosomiasis. Korean J Intern Med 2007; 22: 283-286 [PMID: 18309689 DOI: 10.3904/kjim.2007.22.4.283]
46. Yuen MF, Tanaka Y, Fong DY, Fung J, Wong DK, Yuen JC, But DY, Chan AO, Wong BC, Mizokami M, Lai CL. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol 2009; 50: 80-88 [PMID: 18977053 DOI: 10.1016/j.jhep.2008.07.023]
47. Sun Z, Chen T, Thorgeirsson SS, Zhan Q, Chen J, Park JH, Lu P, Hsia CC, Wang N, Xu L, Lu L, Huang F, Zhu Y, Lu J, Ni Z, Zhang Q, Wu Y, Liu G, Wu Z, Qu C, Gail MH. Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China. Carcinogenesis 2013; 34: 1800-1805 [PMID: 23322152 DOI: 10.1093/carcin/bgt007]
48. Kurokawa M, Hiramatsu N, Oze T, Yakushijin T, Miyazaki M, Hosui A, Miyagi T, Yoshida Y, Ishida H, Tatsumi T, Kiso S, Kanto T, Kasahara A, Iio S, Doi Y, Yamada A, Oshita M, Kaneko A, Mochizuki K, Hagiwara H, Mita E, Ito T, Inui Y, Katayama K, Yoshihara H, Imai Y, Hayashi E, Hayashi N, Takehara T. Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection. J Gastroenterol 2012; 47: 577-585 [PMID: 22231575 DOI: 10.1007/s00535-011-0522-7]